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Edited by Maurice MontalAbstract Aquaporin-1 (AQP1) inhibitors are predicted to have
multiple clinical applications. Hg++ is a non-speciﬁc and toxic
AQP1 blocker. We compared compounds with reported AQP1
inhibition activity, including DMSO, Au+++, Ag+, tetraethylam-
monium and acetazolamide. Water permeability was measured
by stopped-ﬂow light scattering in erythrocytes and volume mar-
ker dilution in epithelial cells. Au+++ inhibited AQP1 with
IC50  14 lM, similar to 10 lM for Hg++. DMSO slowed
osmotic equilibration; however, the apparent inhibition was due
to ‘osmotic clamp’ rather than AQP1 inhibition. Neither tetrae-
thylammonium nor acetazolamide (to 10 mM) inhibited AQP1.
Our data indicate the need to identify new AQP1 inhibitors.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Drug discovery1. Introduction
The aquaporins (AQPs) are a family of molecular water
transporting proteins of molecular size 30 kDa per mono-
mer. There are >10 mammalian AQPs, which are expressed
in cell plasma membranes of various epithelial, endothelial
and other cell types [1–3]. AQP1 is an eﬃcient water transport-
ing protein that does not transport H+, urea or other small sol-
utes [4,5]. It has been reported that AQP1 may also transport
K+ and gases such as CO2 [6–9], though signiﬁcant conﬂicting
data exist [10–12]. AQP1 monomers are assembled in mem-
branes as tetramers, though each monomer contains its own
narrow pore for passage of water. High-resolution structural
data [13,14] indicate that AQP1 monomers contain six a-heli-
cal, membrane-spanning segments surrounding a narrow pore,
with smaller domains that partially reside in the pore and con-
fer water selectivity.
AQP1 is expressed in various epithelia (kidney proximal tu-
bule, choroid plexus, ciliary body) and endothelia (microcapil-
laries, intestinal lacteals, lymphatics). Phenotype analysis of
AQP1 knock-out mice indicate involvement of AQP1 in epi-
thelial cell ﬂuid absorption and secretion, angiogenesis and cell
migration (reviewed in Ref. [1]). AQP1 null mice manifest
defects in urinary concentrating ability [15,16] and tumor angi-*Corresponding author. Fax: +1 4156653847.
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by the choroid plexus [18], and of aqueous ﬂuid by the ciliary
epithelium [19]. Rare humans lacking functional AQP1 mani-
fest a qualitatively similar urinary concentrating defect to mice
[20]. The phenotype data provide compelling rationale for
evaluation of AQP1 inhibitors as diuretics, and as anti-secre-
tory and anti-angiogenic agents for potential therapy of con-
gestive heart failure, hypertension, glaucoma, tumor growth
and spread, and other disorders.
The best established water channel inhibitors are sulfhydryl-
reactive mercurials such as HgCl2; however, they are non-spe-
ciﬁc in their action and toxic to living cells. Mercurials inhibit
AQP1 water permeability by covalent modiﬁcation of cysteine-
187 in the AQP1 sequence, as C187A and related AQP1
mutants are mercurial-insensitive [21,22]. As described in Sec-
tion 4, a variety of other small molecules have been reported to
inhibit AQP1 water permeability, including Au+++ and Ag+
[23], tetraethylammonium (TEA+) [24], acetazolamide [25]
and DMSO [26]. Based on initial data showing DMSO inhib-
ited water permeability in kidney vesicles [26], DMSO has been
assumed to be a general inhibitor of AQP-facilitated water
transport and hence DMSO inhibition has been taken to indi-
cate AQP expression and function [27–31]. TEA+ and aceta-
zolamide have been proposed as lead candidates for clinical
development [32,33]. The purpose of this study is to compare
Hg++ with other candidate compounds for AQP1 inhibition
potency and eﬃcacy. For these studies we used two sensitive,
complimentary assays of AQP1-facilitated water transport,
involving native AQP1-expressing erythrocytes, and stably
transfected AQP1-expressing epithelial cells.2. Material and methods
2.1. Erythrocytes and epithelial cell cultures
Human venous blood was obtained from three donors. Blood was
collected into Vacutainers coated with sodium heparin (Becton–Dick-
inson, Franklin Lakes, NJ). Mouse blood was collected from 8 to
12 week-old (25–35 g) wildtype or AQP1-null mice [15] in a CD1 genet-
ic background by tail bleeding following subcutaneous injection with
sodium heparin (150 USP units). Animal protocols were approved
by the University of California, San Francisco Committee on Animal
Research.
Fisher rat thyroid epithelial (FRT) cells stably expressing AQP1 [17]
were grown in F12-Coombs medium (Sigma-Aldrich, St. Louis, MO)
supplemented with 10% fetal bovine serum (Hyclone), penicillin G
(100 U/ml), streptomycin (100 lg/ml) and geneticin (500 lg/ml) (antibi-
otic selection marker). For dye-dilution experiments, FRT cells were
plated onto Transwell inserts (Corning Inc., Corning, NY) and used
for ﬂux measurements at resistances of 2–5 kX cm2.European Biochemical Societies.
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DMSO, hydroxyurea, HAuCl4 (Au
+++), AgNO3 (Ag
+), HgCl2
(Hg++), tetraethylammonium (TEA+), tetrapropylammonium (TPrA+)
and acetazolamide were purchased from Sigma–Aldrich. Solutions
were freshly prepared just before experiments. For experiments with
AgNO3 all Cl
 was replaced by NO3 .
2.3. Stopped-ﬂow light scattering measurements
Freshly obtained erythrocytes were washed three times in PBS to
remove plasma and the cellular buﬀy coat. Stopped-ﬂow measurements
were done on a Hi-Tech Sf-51 instrument. Suspensions of erythrocytes
(0.5% hematocrit) in PBS were subjected to a 250 mM inwardly di-
rected gradient of sucrose. The kinetics of decreasing cell volume
was measured from the time course of 90 scattered light intensity at
530 nm wavelength. Osmotic water permeability coeﬃcients (Pf) were
computed from the light scattering time course, as described [10]. In
some experiments, DMSO, hydroxyurea, Au+++, Ag+, TEA+, TPrA+,
acetazolamide or Hg++ were added to the erythrocyte suspension and
the hyperosmolar sucrose solution (500 mM sucrose in PBS) for
15 min (or up to 4 h) before stopped-ﬂow experiments.
For measurement of DMSO and hydroxyurea permeabilities, the
erythrocyte suspension in PBS was subjected to a 250 mM inwardly
directed gradient of these solutes at 10 C. The kinetics of decreasing
cell volume was measured by light scattering as described above. Per-
meability coeﬃcients (PDMSO and Phydroxyurea) were computed from
the relation: Ps = 1/[(S/V)s], where S/V is surface-to-volume ratio
and s is the exponential time constant ﬁtted to the cell swelling phase
of the light scattering time course corresponding to solute entry.2.4. Transepithelial water permeability measurements
Osmotic water permeabilities across FRT cell layers were deter-
mined using a dye dilution method, as described [34]. The dilution of
a cell-impermeant, inert dye (Texas Red-dextran, 10 kDa, Molecular
Probes, Eugene, OR) was used as a measure of transcellular osmotic
water ﬂux. The basal surface of cells on a porous ﬁlter was bathed
in 1 ml of isosmolar PBS. The apical surface was bathed in 200 ll of
hyperosmolar PBS (PBS + 300 mM D-mannitol) containing 0.25 mg/
ml Texas Red-dextran. In some experiments, TEA+ or acetazolamide
(dissolved freshly from powder) was added to both the apical and ba-
sal-bathing buﬀers. Five ll samples of dye-containing apical ﬂuid was
collected at speciﬁed times. Samples were diluted in 2 ml of PBS and
ﬂuorescence was measured by cuvette ﬂuorimetry (Fluoro Max-3,
Horiba, Tokyo, Japan). Transepithelial osmotic water permeability
coeﬃcients (Pf in cm/s) were computed from indicator dilution data,
as described [34].2.5. Simulations of DMSO eﬀect on osmotic equilibration
Coupled osmotic water and solute transport across the erythrocyte
plasma membrane was modeled using the ﬂux equations: Water ﬂux
– J v ðin cm3=sÞ ¼ P f  S  vw  ½ðI e  IcðiÞÞ þ ðU e  U cðiÞÞ; Solute ﬂux
– J sðin mol=sÞ ¼ P s  S  ðU e  U cðiÞÞ. Permeability coeﬃcients (Pf and
Ps) are expressed in units of cm/s, cell surface area (S) in cm
2, extracel-
lular (e) and cellular (c) concentrations of impermeant (I) and perme-
ant (U) solute (DMSO) in mol/cm3, and vw is 18 mol/cm
3. The
equations were numerically integrated as described [35], assuming
unity solute reﬂection coeﬃcient. Pf and Ps (PDMSO and Phydroxyurea)
were determined experimentally. Appropriate initial conditions were
chosen to simulate eﬀects of DMSO on the kinetics of V(t), assumed
to be related inversely to scattered light intensity.3. Results
3.1. Eﬀect of putative AQP1 inhibitors on erythrocyte water
permeability
Putative inhibitors of AQP1 were screened at high concen-
tration in erythrocytes from wildtype mice, including TEA+
(and its analog TPrA+), heavy metal ions (Hg++, Au+++ and
Ag+) and acetazolamide. Measurements were done at low tem-
perature (10 C), where the strongly temperature-dependent li-
pid-mediated water permeability is minimized. Erythrocyteosmotic equilibration was rapid (250 ms) in wildtype mice
under control condition (Fig. 1A). At 100 lM, substantial
inhibition was seen for Hg++, Au+++ and Ag+, though no inhi-
bition was seen for TEA+, TPrA+ or acetazolamide. No signif-
icant eﬀect of these compounds was seen in AQP1-null
erythrocytes, where water permeability was greatly slowed, rul-
ing out non-speciﬁc compound eﬀects on AQP1-independent
water transport (primarily through erythrocyte membrane lip-
ids). Consistent with our previous results [36], mouse erythro-
cytes do not contain non-AQP1 mercurial-sensitive water
channels. Averaged osmotic water permeability coeﬃcients
(Pf) are summarized in Fig. 1B, showing standard errors from
3 sets of studies, each done on blood from diﬀerence mice.
Concentration–inhibition data is summarized in Fig. 2.
Comparable, near-complete inhibition of water transport was
found for higher concentrations of Hg++, Au+++ and Ag+,
with IC50 values of approximately 10, 14 and 6 lM, respec-
tively. No signiﬁcant inhibition was seen for TEA+, TPrA+
(each 10 mM) or acetazolamide (2 mM, solubility limit)
(Fig. 2) even after incubation with erythrocytes for 1 and 4 h
(not shown).
Because no inhibition was found for TEA+, TPrA+ or acet-
azolamide in mouse erythrocytes, measurements were done on
human erythrocytes and on AQP1-expressing epithelial cells.
As is well-known, Pf is lower in human than in mouse erythro-
cytes. Au+++, Ag+ and Hg++ strongly reduced water perme-
ability in human erythrocytes when measured at 10 C
(Fig. 3A) or 23 C (Fig. 3B). No signiﬁcant inhibition was
found for TEA+, TPrA+ or acetazolamide.3.2. Transepithelial water permeability in AQP1-expressing
FRT cells
Measurements of transepithelial water permeability were
done in AQP1-expressing FRT epithelial cells using a dye dilu-
tion method. The ﬂuorescence of an apical solution volume
marker provided a quantitative readout of osmotically driven
water transport across the cell layer. Transepithelial Pf was
deduced from the kinetics of dye dilution in response to a
300 mM gradient of mannitol to induce basolateral-to-apical
osmotic water ﬂux. Dye dilution was much faster in AQP1-
expressing vs. control (non-transfected) FRT cells, with no
signiﬁcant diﬀerence seen in AQP1-expressing cells that were
pre-treated for 15 min with 1 mM TEA+ or acetazolamide
(Fig. 4A). Fig. 4B summarizes transepithelial Pf values.3.3. DMSO slows osmotic equilibration but is not an AQP1
inhibitor
DMSO (0–2% wt/vol) was tested as an inhibitor of erythro-
cyte water permeability by addition to the erythrocyte
suspension and the hyperosmolar sucrose solution prior to
stopped-ﬂow measurements. Similar to prior data on kidney
vesicles [26], DMSO produced a concentration-dependent
reduction in the apparent rate of osmotic equilibration
(Fig. 5A), as seen best from the slowed equilibration at long
times. To compute absolute (corrected) Pf, the Kedem–Kat-
chalsky equations for coupled water/solute ﬂow were numeri-
cally integrated using a DMSO permeability coeﬃcient
(PDMSO) of 1.5 · 106 cm/s, as measured by stopped-ﬂow light
scattering (Fig. 5B, top). Fig. 5C shows simulated stopped-
ﬂow kinetics computed with constant erythrocyte Pf. DMSO
was predicted to produce apparent slowing of osmotic equili-
Fig. 1. Osmotic water permeability in mouse erythrocytes measured by stopped-ﬂow light scattering. Osmotic water permeability was measured from
the time course of scattered light intensity in response to a 250 mM inwardly directed sucrose gradient. (A) Measurements in erythrocytes from
wildtype and AQP1 null mice done at 10 C under control conditions (top curves) and in the presence of indicated inhibitors (each 100 lM).
Erythrocytes were incubated with test compounds for 15 min before measurements. Activities of TEA+ for K+ channel inhibition and of
acetazolamide for carbonic anhydrase inhibition were conﬁrmed. (B) Averaged osmotic water permeability coeﬃcients (Pf) for experiments as in (A)
done in erythrocytes from wildtype mice (top) and AQP1 null mice (bottom) (means ± S.E., 3 mice of each genotype, 8 separate measurements per
mouse). *P < 0.01 compared to control.
Fig. 2. Concentration–inhibition analysis for water transport inhibi-
tion in erythrocytes from wildtype mice. Experiments done as in Fig. 1.
Each point is means ± S.E. (8 measurements) with ﬁtted single-site
inhibition curve shown.
Fig. 3. Osmotic water permeability in human erythrocytes measured
by stopped-ﬂow light scattering. Experiments done as in Fig. 1, but in
human erythrocytes. (A) Averaged osmotic water permeability coef-
ﬁcients (Pf) (means ± S.E., n = 8) measured at 10 C. (B) Pf measured
at 23 C. *P < 0.01 compared to control.
Fig. 4. Transepithelial osmotic water permeability in AQP1-transfec-
ted FRT cell cultures. Water permeability of control and AQP1-
expressing FRT cells at 23 C measured by dye dilution as described
under Materials and Methods. (A) Kinetics of dye dilution in control
(non-transfected) FRT cells (open circles) and AQP1-expressing FRT
cells (closed circles). Cells were incubated with 1 mM TEA+ or 1 mM
acetazolamide as indicated. Each point is means ± S.E. for 3 exper-
iments. Single-exponential ﬁts shown as solid lines. (B) Summary of Pf
values. Diﬀerences in AQP1-transfected FRT cells with TEA+ and
acetazolamide not signiﬁcant.
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that DMSO is not a bona ﬁde AQP1 inhibitor – that slowing
of osmotic equilibration is a consequence of its high osmolality
and transport rate (‘osmotic-clamp’ eﬀect).
As further evidence that DMSO is not an AQP1 inhibitor,
we screened a series of small solutes to identify a solute with
permeability similar to that of DMSO. As shown in Fig. 5B
(bottom), hydroxyurea has near identical permeability to
DMSO. Fig. 5D shows stopped-ﬂow light scattering measure-
ments done as in Fig. 5A, except for hydroxyurea in place of
DMSO. The apparent inhibition of erythrocyte osmotic water
Fig. 5. Characterization of DMSO slowing of osmotic equilibration.
(A) Stopped-ﬂow light scattering measurements of osmotic water
permeability in mouse erythrocytes in response to a 250 mM inwardly
directed sucrose gradient in the absence or presence of indicated
concentrations of DMSO. (B) Measurements of DMSO (top) and
hydroxyurea (bottom) permeabilities. Light scattering time course
shown in response to a 250 mM inwardly directed gradient of each
solute. (C) Predicated erythrocyte volume change for simulations of
experiments in (A). Parameters: Pf = 0.025 cm/s, PDMSO = 1.5 · 106
cm/s. (D) Water transport measurements as in (A) except for
replacement of DMSO by hydroxyurea.
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DMSO, supporting the conclusion that DMSO is not an
AQP1 inhibitor.4. Discussion
The purpose of this study was to evaluate the eﬃcacy and po-
tency of several unrelated compounds that have been reported
as AQP1 inhibitors. Our data conﬁrmed AQP1 inhibition by
the metal ions Ag+ and Au+++, as reported [23], in agreement
with the older literature showing water channel inhibition by
Hg++ and various other heavy metal ions [37–39]. Although
Au+++ and Ag+ eﬀectively inhibited AQP1 water permeability,
they are not useful for development as clinically useful AQP1
inhibitors because they are predicted to be non-speciﬁc in their
action. Ag+ is insoluble in physiological Cl-containing
solutions, and Au+++ would be toxic at concentrations needed
to inhibit AQP1 water permeability. DMSO was conﬁrmed to
slow osmotic equilibration, as found many years ago [26],
though its mechanism-of-action was determined to involve
‘osmotic-clamp’ rather than direct AQP1 inhibition. We found
no signiﬁcant inhibition of AQP1 by TEA+ or acetazolamide,
which contradicts prior results.
DMSO was ﬁrst proposed to be a water transport inhibitor
in stopped-ﬂow light scattering measurements on renal proxi-
mal tubule vesicles [26], where water moves primarily through
AQP1. However, the conclusion that DMSO inhibited water
permeability was based on an incorrect interpretation that re-
duced amplitude (rather than altered kinetics) of their lightscattering data in terms of water transport inhibition. Reduced
signal amplitude likely represents a combination of DMSO
osmotic eﬀect, which lessens vesicle volume change, and
DMSO-increased solution refractive index, which reduces light
scattering intensity. DMSO then acquired the unjustiﬁed repu-
tation as a general AQP water transport blocker, and subse-
quent papers have taken DMSO inhibition of osmotic
equilibration as evidence for AQP-facilitated water transport.
Our ﬁndings here indicate that DMSO slowing of osmotic
water equilibration is a predictable eﬀect of its signiﬁcant
osmolality and rapid membrane permeation. Similar slowing
of osmotic equilibration was predicted and found for an unre-
lated small solute, hydroxyurea, which has similar molecular
size and membrane permeability to DMSO. The extent of
slowing of osmotic equilibration depends on membrane water
and DMSO permeabilities, and DMSO concentration. The
predicted lesser eﬀect of DMSO on osmotic water equilibra-
tion when water permeability is low probably accounts, in
part, for the erroneous conclusion that DMSO is a general
AQP inhibitor. We conclude that apparent inhibition of water
transport by high millimolar concentrations of DMSO or
other small, uncharged solutes cannot be taken as evidence
for functional AQP expression.
TEA+ is a well-known pore-occluding blocker of voltage-
gated potassium channels [40,41]. The Yool lab ﬁrst reported
TEA+ inhibition of AQP1. TEA+ at 100 lM inhibited water
permeability of heterologously expressed human AQP1 in
Xenopus oocytes by >20%, increasing to nearly 40% by
10 mM [24]. In a follow-up study Yool et al. [42] reported 30–
40% inhibition of water transport by 10 mM TEA+ in AQP1-
expressing MDCK cells and perfused thin descending limbs of
Henle (TDLH) from rat kidney. Detmers et al. [33] also mea-
sured water permeability in AQP1-expressing Xenopus oocytes,
reporting 40% inhibition of water permeability by 100 lM
TEA+ and lesser inhibition by several TEA+ analogs. TEA+
inhibition of water permeability was found for other AQPs as
well, and TEA+ inhibition of AQP1 water permeability was re-
duced after mutagenesis of some single residues.
We cannot account for the diﬀerences in the data here with
those of the previous reports. Perhaps oocytes contain a
TEA+-sensitive membrane protein or lipid component that
interacts with AQP1. However, the study of Yool et al. [42]
in TDLH could not be explained by oocyte-speciﬁc factor(s),
though the reported TDLH data was associated with large
statistical variability. Also, apparent water transport may be
inﬂuenced by non-speciﬁc eﬀects of the high (10 mM) TEA+
concentrations such as block of K+ channels and consequent
altered basal cell volume. Our data show that TEA+ does
not inhibit AQP1 water permeability in erythrocytes or
AQP1-expressing epithelial cells at concentrations up to
10 mM, under assay conditions in which <10% inhibition
would be easily detectable. The erythrocyte stopped-ﬂow and
transepithelial water permeability measurements have substan-
tially less variation than oocyte water permeability measure-
ments. We conclude that TEA+ is not a robust inhibitor of
mouse or human AQP1, and therefore not a ‘lead compound’
for clinical development.
The sulfanilamide carbonic anhydrase inhibitor acetazola-
mide was reported by Ma et al. [25] to inhibit water permeabil-
ity by >80% at 10 lM in Xenopus oocytes, with IC50  1 lM.
A follow-up study from the same group [32] reported 40%
inhibition of water permeability by 100 lM acetazolamide in
B. Yang et al. / FEBS Letters 580 (2006) 6679–6684 6683transfected HEK cells. They reported evidence by surface plas-
mon resonance of a possible direct interaction between AQP1
and acetazolamide that could account for the inhibition. Other
somewhat conﬂicting data from the same group showed acet-
azolamide inhibited AQP1 protein expression, angiogenesis
and tumor metastasis [43,44]. Here, we found no inhibition
of AQP1 water transport in erythrocytes or AQP1-expressing
epithelial cells at concentrations of acetazolamide up to
2 mM. We believe that studies from the Li group suggesting
that acetazolamide is an AQP1 down-regulator and inhibitor
are ﬂawed in their design and interpretation.
In summary, our data conﬁrm the inhibition of AQP1 by the
heavy metal ions Au+++ and Ag+, but do not support the con-
clusions that TEA+ or acetazolamide inhibit AQP1, or that
DMSO is a general AQP inhibitor. Because of the multiple
potential clinical indications of AQP1 inhibitors as mentioned
in the introduction, our results underscore the need for small-
molecule discovery eﬀorts to identify non-toxic, AQP1-selec-
tive inhibitors suitable for clinical use.
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